A detailed history of Baker Avenue Asset Management, LP transactions in Zoetis Inc. stock. As of the latest transaction made, Baker Avenue Asset Management, LP holds 24,615 shares of ZTS stock, worth $4.05 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
24,615
Previous 24,247 1.52%
Holding current value
$4.05 Million
Previous $4.2 Million 14.42%
% of portfolio
0.14%
Previous 0.12%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$172.58 - $196.48 $63,509 - $72,304
368 Added 1.52%
24,615 $4.81 Million
Q2 2024

Aug 07, 2024

BUY
$145.54 - $178.83 $35,802 - $43,992
246 Added 1.02%
24,247 $4.2 Million
Q1 2024

May 10, 2024

BUY
$165.67 - $199.94 $198,969 - $240,127
1,201 Added 5.27%
24,001 $4.06 Million
Q4 2023

Feb 13, 2024

BUY
$151.44 - $200.09 $215,347 - $284,527
1,422 Added 6.65%
22,800 $4.5 Million
Q3 2023

Nov 14, 2023

BUY
$167.14 - $192.77 $487,714 - $562,502
2,918 Added 15.81%
21,378 $3.72 Million
Q2 2023

Aug 11, 2023

BUY
$160.94 - $186.23 $1.18 Million - $1.37 Million
7,350 Added 66.16%
18,460 $3.18 Million
Q1 2023

May 15, 2023

BUY
$145.48 - $175.02 $1.62 Million - $1.94 Million
11,104 Added 185066.67%
11,110 $1.85 Million
Q4 2022

Feb 13, 2023

SELL
$131.14 - $157.47 $240,641 - $288,957
-1,835 Reduced 99.67%
6 $0
Q3 2022

Nov 14, 2022

SELL
$148.29 - $182.55 $83,190 - $102,410
-561 Reduced 23.36%
1,841 $273,000
Q2 2022

Aug 03, 2022

SELL
$155.97 - $200.09 $2,651 - $3,401
-17 Reduced 0.7%
2,402 $413,000
Q1 2022

May 16, 2022

SELL
$181.39 - $234.03 $452,023 - $583,202
-2,492 Reduced 50.74%
2,419 $456,000
Q4 2021

Feb 11, 2022

BUY
$193.69 - $247.03 $951,211 - $1.21 Million
4,911 New
4,911 $1.2 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.1B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Baker Avenue Asset Management, LP Portfolio

Follow Baker Avenue Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Avenue Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Baker Avenue Asset Management, LP with notifications on news.